Drugs 2004; 64 (17): 1861-1891
نویسندگان
چکیده
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1862 1. Androgen Replacement Therapy: General Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1862 1.1 Testosterone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1862 1.2 Estrogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1864 1.3 Nongenomic Actions of Androgens and Estrogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1865 1.4 Transport of Androgens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1865 1.5 Quantitative Aspects of Androgen Action . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1865 1.6 Plasma Testosterone Levels Required for Androgen-Related Biological Functions . . . . . . . . . 1865 2. Available Preparations for Testosterone Replacement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1866 3. Oral and Sublingual Administration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1866 3.1 Transdermal Delivery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1869 3.1.1 Scrotal Testosterone Patch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1869 3.1.2 Nonscrotal Testosterone Patch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1870 3.1.3 Testosterone Gel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1870 3.2 Intramuscular Administration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1871 3.2.1 Testosterone Esters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1871 3.2.2 Testosterone Bucyclate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1872 3.2.3 Testosterone Microspheres . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1872 3.2.4 Testosterone Undecanoate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1872 3.3 Testosterone Implants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1872 3.4 Androgen Replacement with 5α-Reduced Testosterone: 5α-Dihydrotestosterone . . . . . . . . 1874 4. Adequacy of Androgen Replacement: Biochemical and Clinical Endpoints . . . . . . . . . . . . . . . . . 1875 4.1 Recent Insights into Androgen Action . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1876 5. Towards Novel Androgen Preparations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1876 6. A Selective Androgen: 7α-Methyl-19-Nortestosterone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1877 7. Target Organs of Androgens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1878 7.1 Muscles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1878 7.2 Bones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1878 7.3 Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1879 7.4 Androgens and Sexual Functioning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1879 7.5 Androgens and Cognitive Performance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1879 7.6 Estrogenic Actions of Androgens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1880 8. Modifications to Limit Potentially Negative Effects of Androgens . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1881 8.1 Cardiovascular Aspects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1881 8.2 Prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1881 8.2.1 Estrogens and Prostate Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1882 9. Requirements for the Various Androgen Treatment Indications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1883 9.1 Induction of Virilisation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1883 9.2 Maintenance of Virilisation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1884 9.3 Aging Males . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1884 9.4 Androgen Administration to Women . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1884 10. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1884
منابع مشابه
Labour Migration in Southern and Eastern England, 1861-1901
This paper examines the determinants of migration from 19 southern counties to six major destinations in England and Wales from 1861-70 to 1891-1900. I find that, while the size of origin-destination wage gaps and the distance between origin and destination areas were important determinants of migration flows, as expected, migration was also strongly influenced by the number of previous migrant...
متن کاملNineteenth-Century Nurses and Midwives in Three Canadian Cities, 1861-1891.
This paper focuses on nurses and midwives in Montreal, Halifax, and Saint John in the decades leading up to the introduction of trained nurses. Self-employed (private) nurses are compared with those in hospitals. Overwhelmingly of the working-class, predominantly women, and frequently widows, the nurses were not formally trained, though some midwives were. Comparisons are made between nurses an...
متن کاملStatistics of Cases of Tetanus Treated in the Medical College Hospital during 1861-62-63 and 64, Showing Its Rates of Mortality and Cure, as Also Its Prevalence, in Different Months and Years
متن کامل
Contract Report 2003-09 Temporal Behavior of the Levels of Middle and Upper Great Lakes Reveals Major Space and Time Climate Differences During 1861-2001
متن کامل
Medical expertise as a historical phenomenon and academic discipline.
Based on secondary literature, a survey of particular forms of medical expertise over history is presented. The state-to-individual interaction in terms of personality and physical integrity protection, health care, etc., was observed. It was only after the 16th century that the development of anatomy was found to have become a decisive argument for convincing expertise in various trials. In Cr...
متن کامل